MIB-1 monoclonal antibody to determine proliferative activity of Ki-67 antigen as an adjunct to the histopathologic differential diagnosis of Spitz nevi

被引:77
作者
Bergman, R
Malkin, L
Sabo, E
Kerner, H
机构
[1] Technion Israel Inst Technol, Rambam Med Ctr, Dept Dermatol, IL-31096 Haifa, Israel
[2] Technion Israel Inst Technol, Rambam Med Ctr, Dept Pathol, IL-31096 Haifa, Israel
[3] Technion Israel Inst Technol, Rambam Med Ctr, Dermatopathol Unit, IL-31096 Haifa, Israel
[4] Technion Israel Inst Technol, Bnai Zion Med Ctr, Dept Pathol, IL-31096 Haifa, Israel
[5] Technion Israel Inst Technol, Bruce Rappaport Fac Med, IL-31096 Haifa, Israel
关键词
D O I
10.1067/mjd.2001.111635
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: The histopathologic differential diagnosis of Spitz nevus (SN) from malignant melanoma (MM) may be difficult. Objective: Our purpose was to determine the staining pattern and usefulness of MIB-1 antibody, which recognizes Ki-67 antigen in formalin-fixed, paraffin-embedded tissue, as an adjunct to the histopathologic differential diagnosis of SN. Methods: Twenty-five compound SNs, 27 MMs, and 26 compound nondysplastic melanocytic nevi (MNs) were immunostained with the MIB-1 antibody. Results: The mean counts of MIB-1-stained tumor cells of the epiderm:ll and dermal components, both alone and together, were significantly lower in SNs and MNs than in MMs (P < .0001). The dermal counts showed the best discriminating power. In addition, the mean dermal/epidermal count ratios for MIB-1 in SNs and MNs (0.25 and 0.23, respectively) were significantly lower than the corresponding ratio (0.94) in MMs (P < .0001). Conclusion: MIB-1-stained tumor cell counts, especially of the dermal component, anti dermal/epidermal MIB-1 count ratios may be helpful as an adjunct to the histopathologic differential diagnosis of SN.
引用
收藏
页码:500 / 504
页数:5
相关论文
共 22 条
[21]  
Wakimoto H, 1996, CANCER-AM CANCER SOC, V77, P373, DOI 10.1002/(SICI)1097-0142(19960115)77:2<373::AID-CNCR21>3.0.CO
[22]  
2-Y